These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 1803618

  • 21. Factor IX alloantibodies shorten the bovine thromboplastin coagulation time of normal human plasma.
    Orstavik KH.
    Thromb Haemost; 1981 Dec 23; 46(4):684-6. PubMed ID: 7330818
    [Abstract] [Full Text] [Related]

  • 22. Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia B.
    Liles D, Landen CN, Monroe DM, Lindley CM, Read MS, Roberts HR, Brinkhous KM.
    Thromb Haemost; 1997 May 23; 77(5):944-8. PubMed ID: 9184407
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Evaluation of coagulation equilibrium at baseline and during factor VIII and factor IX replacement in haemophiliacs.
    Négrier C, Menart C, Attali O, Petit PY, Lienhart A, Dechavanne M, Ingerslev J.
    Blood Coagul Fibrinolysis; 1998 Mar 23; 9 Suppl 1():S135-41. PubMed ID: 9819045
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. An international collaborative study establishing a reference preparation for Antithrombin III.
    Kirkwood TB, Barrowcliffe TW, Thomas DP.
    Thromb Haemost; 1980 Feb 29; 43(1):10-5. PubMed ID: 7404474
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Heat treated New Zealand factor IX concentrate: comparison with Prothrombinex in patients with haemophilia B.
    Benny AG, Ockelford PA, Johns AS, Woodfield DG, Berry EW.
    N Z Med J; 1986 Jun 11; 99(803):408-9. PubMed ID: 3461352
    [Abstract] [Full Text] [Related]

  • 31. A test method for the absence of thrombogenicity in factor IX complex.
    Miura Y, Abe T, Kazama M, Yasuda J.
    Dev Biol Stand; 1979 Jun 11; 44():189-97. PubMed ID: 544293
    [Abstract] [Full Text] [Related]

  • 32. Isolation and characterization of canine factor IX.
    Sugahara Y, Catalfamo J, Brooks M, Hitomi E, Bajaj SP, Kurachi K.
    Thromb Haemost; 1996 Mar 11; 75(3):450-5. PubMed ID: 8701406
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Factor IX Zutphen. A genetic variant of blood coagulation factor IX with an abnormally high molecular weight.
    Bertina RM, Van Der Linden IK.
    J Lab Clin Med; 1982 Nov 11; 100(5):695-704. PubMed ID: 7130828
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Evaluation of factor VIII deficient plasmas.
    Barrowcliffe TW, Tubbs JE, Wong MY.
    Thromb Haemost; 1993 Sep 01; 70(3):433-7. PubMed ID: 8259544
    [Abstract] [Full Text] [Related]

  • 37. Standardization of Factor VIII-III. Establishment of a stable reference plasma for Factor VIII-related activities.
    Barrowcliffe TW, Tydeman MS, Kirkwood TB, Thomas DP.
    Thromb Haemost; 1983 Oct 31; 50(3):690-6. PubMed ID: 6417818
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Bleeding symptoms in carriers of hemophilia A and B.
    Mauser Bunschoten EP, van Houwelingen JC, Sjamsoedin Visser EJ, van Dijken PJ, Kok AJ, Sixma JJ.
    Thromb Haemost; 1988 Jun 16; 59(3):349-52. PubMed ID: 2847347
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.